Stay updated on Sorafenib Nivolumab in Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the Sorafenib Nivolumab in Liver Cancer Clinical Trial page.

Latest updates to the Sorafenib Nivolumab in Liver Cancer Clinical Trial page
- Check5 days agoChange DetectedThe page revision was updated to v3.5.4, replacing the previous v3.5.3. This indicates a backend version update without altering the displayed study details.SummaryDifference0.0%

- Check12 days agoChange DetectedA new citation for a 2026 JHEP Reports article is added to Publications, listing the authors and providing full bibliographic details including the DOI and online-ahead-of-print status.SummaryDifference0.0%

- Check19 days agoChange DetectedThe page's revision metadata was updated to v3.5.3, replacing the previous v3.5.2 to reflect the latest documentation state.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2, indicating an updated build of the page.SummaryDifference0.0%

- Check62 days agoChange Detected- Publications section was added, including a new PubMed reference: Phase II trial with nivolumab and sorafenib in HCC identified enrichment of immunosuppressive monocytes in patients with Child-Pugh B liver dysfunction. These publications are automatically filled from PubMed.SummaryDifference0.4%

- Check69 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Sorafenib Nivolumab in Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sorafenib Nivolumab in Liver Cancer Clinical Trial page.